Aeglea Biotherapeutics Inc. – Investors and Politicians Who Own It

SYRE, 2 share classes and securities

Investors who own it

3 tracked investors, $786.2M in shares, each from their latest 13F.

InvestorValueShare of portfolio
Joseph EdelmanPerceptive Advisors, Q2 2026
$383.5M5.76%
Rod WongRTW Investments, Q2 2026
$377.5M3.22%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$25.2M1.15%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

No member of Congress is estimated to hold this stock.

InvestorActionShares now
Joseph EdelmanAdded +150%3,069,225
Rod WongAdded +15%4,171,996
Peter KolchinskyNew1,621,620

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

No disclosed Congress trades in this stock.